Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenzhujing Tablets for Qi and Yin Deficiency–Related Fatigue Syndromes
ChiCTR2400088639Phase 4Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Aug 2024
- Countries
- 1
01
Overview
Phase 4, randomised trial of Shenzhujing Tablets in myalgic encephalomyelitis (ME), cancer-related fatigue (CRF), asthenia and 2 more (8 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Chinese Medicine Syndrome Scores at week 4. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
Shenzhujing Tablets
03
Conditions
myalgic encephalomyelitis (ME)cancer-related fatigue (CRF)astheniatype 2 diabetes mellitus (T2DM)Tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2400088639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088639.